시장보고서
상품코드
1485096

근시 및 노안 치료 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측, 근시 치료 유형별, 노안 치료 유형별, 지역별, 경쟁사별(2019-2029년)

Myopia And Presbyopia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Myopia Treatment Type, By Presbyopia Treatment Type, by region, and Competition, 2019-2029F

발행일: | 리서치사: TechSci Research | 페이지 정보: 영문 180 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 근시 및 노안 치료 시장은 2023년 172억 달러 규모로 2029년까지 연평균 8.30%의 성장률로 예측 기간 동안 괄목할 만한 성장을 이룰 것으로 예상됩니다. 근시는 일반적으로 근시로 알려져 있으며, 멀리 있는 것은 흐릿하게 보이지만 가까운 것은 선명하게 보이는 시력 상태입니다. 근시는 안구가 너무 길거나 각막이 너무 구부러져 빛이 망막에 직접 초점을 맺지 않고 망막 앞쪽에 초점을 맺는 현상으로 인해 발생합니다. 오목렌즈 안경을 착용하면 빛이 망막에 정확히 초점을 맺도록 방향이 바뀌어 근시가 교정됩니다. 근시는 안경 처방전에 마이너스 숫자로 표시됩니다. 노안은 나이가 들면서 눈의 수정체가 탄력을 잃어 가까운 곳에 초점을 맞추는 능력에 영향을 미치는 시력 상태입니다. 노안 안경은 근거리 시력을 보조하기 위해 렌즈 도수를 플러스 도수로 설계되어 있습니다. 노안에 대한 간단하고 효과적인 치료법이며, 시중에서 구입하거나 처방전을 통해 구입할 수 있습니다.

시장 개요
예측 기간 2025-2029년
시장 규모 : 2023년 172억 달러
시장 규모 : 2029년 278억 2,000만 달러
CAGR : 2024-2029년 8.30%
급성장 부문 처방전
최대 시장 북미

혁신적인 수술 방법, 진단 도구, 콘택트렌즈 디자인 등 안과 기술의 발전으로 치료 옵션이 확대되고 치료 결과가 개선되고 있습니다. 이러한 기술 발전은 시장 성장의 원동력이 되고 있습니다. 시력 문제에 대한 환자들의 인식이 높아지고 정기적인 안과 검진의 중요성, 치료 옵션의 가용성이 높아짐에 따라 근시 및 노안 치료에 대한 수요가 증가하고 있습니다. 아트로핀 점안제와 같은 근시 억제를 위한 의약품 치료법의 개발이 관심을 끌며 시장 성장의 원동력이 되고 있습니다. 세계 인구의 고령화는 노안 치료 시장의 성장 동력이 되고 있습니다. 나이가 들어감에 따라 노화와 관련된 시력 변화를 겪기 쉬워져 노안 치료제에 대한 수요가 증가하고 있습니다. 정부 및 비정부기구는 근시 및 노안에 대한 인식을 높이고 정기적인 안과 검진을 장려하기 위해 종종 공중 보건 캠페인을 실시합니다.

주요 시장 성장 촉진요인

기술의 발전

고령화 인구 증가

의약품 혁신 증가

주요 시장 과제

수술에 대한 저항력

안전과 효과에 대한 우려

주요 시장 동향

맞춤형 의료

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 근시 및 노안 치료 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 근시 치료 유형별(교정, 수술, 약물)
    • 노안 치료 유형별(처방, 콘택트렌즈, 안내 렌즈, 굴절 교정 수술)
    • 지역별
    • 기업별(2023년)
  • 시장 맵

제6장 북미의 근시 및 노안 치료 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 근시 치료 유형별
    • 노안 치료 유형별
    • 국가별
  • 북미 : 국가별 분석
    • 미국
    • 캐나다
    • 멕시코

제7장 유럽의 근시 및 노안 치료 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 근시 치료 유형별
    • 노안 치료 유형별
    • 국가별
  • 유럽 : 국가별 분석
    • 독일
    • 영국
    • 이탈리아
    • 프랑스
    • 스페인

제8장 아시아태평양의 근시 및 노안 치료 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 근시 치료 유형별
    • 노안 치료 유형별
    • 국가별
  • 아시아태평양 : 국가별 분석
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주

제9장 남미의 근시 및 노안 치료 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 근시 치료 유형별
    • 노안 치료 유형별
    • 국가별
  • 남미 : 국가별 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제10장 중동 및 아프리카의 근시 및 노안 치료 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 근시 치료 유형별
    • 노안 치료 유형별
    • 국가별
  • 중동 및 아프리카 : 국가별 분석
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트(UAE)

제11장 시장 역학

  • 성장 촉진요인
  • 과제

제12장 시장 동향과 발전

  • 최근 동향
  • 제품 출시
  • 인수합병(M&A)

제13장 세계의 근시 및 노안 치료 시장 : SWOT 분석

제14장 경쟁 구도

  • Ziemer Ophthalmic Systems AG
  • NIDEK CO., LTD.
  • Johnson & Johnson Vision Care, Inc.
  • Essilor
  • Carl Zeiss AG
  • Alcon
  • Bausch+Lomb Corporation
  • Haag-Streit UK
  • Topcon Corporation

제15장 전략적 제안

제16장 리서치사에 대해 & 면책사항

LSH 24.06.04

Global Myopia and Presbyopia Treatment Market was valued at USD 17.20 billion in 2023 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 8.30% through 2029. Myopia, commonly known as nearsightedness, is a vision condition where distant objects appear blurry, while close-up objects can be seen clearly. Myopia occurs when the eyeball is too long or the cornea is too curved, causing light to focus in front of the retina instead of directly on it. Wearing eyeglasses with concave lenses corrects myopia by redirecting light to focus correctly on the retina. Myopia is indicated by a negative number on your eyeglass prescription. Presbyopia is an age-related vision condition that affects the ability to focus on near objects due to the loss of elasticity in the eye's crystalline lens. Reading glasses are designed with a positive lens power to aid in close-up vision. They are a simple and effective treatment for presbyopia and are available over the counter or by prescription.

Market Overview
Forecast Period2025-2029
Market Size 2023USD 17.20 Billion
Market Size 2029USD 27.82 Billion
CAGR 2024-20298.30%
Fastest Growing SegmentPrescription
Largest MarketNorth America

Advances in ophthalmic technologies, including innovative surgical procedures, diagnostic tools, and contact lens designs, have expanded treatment options and improved outcomes. These technological advancements drive market growth. Increased awareness among patients about vision issues, the importance of regular eye check-ups, and the availability of treatment options has led to greater demand for myopia and presbyopia treatments. The development of pharmaceutical treatments for myopia control, such as atropine eye drops, has garnered interest and driven market growth. The aging global population is a driver for the presbyopia treatment market. As people get older, they become more susceptible to age-related vision changes, increasing the demand for presbyopia treatments. Government and non-governmental organizations often run public health campaigns to raise awareness about myopia and presbyopia and encourage regular eye check-ups.

Key Market Drivers

Technological Advancements

Low-dose atropine eye drops have shown promise in slowing the progression of myopia in children. This pharmaceutical treatment has gained attention as an alternative to traditional corrective lenses. Ortho-K involves wearing specially designed contact lenses overnight to reshape the cornea. Technological advancements have led to improved lens designs, enhancing safety and efficacy. Laser-assisted refractive surgeries like LASIK and PRK have benefited from femtosecond lasers. These lasers enable more precise corneal reshaping, reducing recovery times and improving outcomes. Digital lens manufacturing has improved the design and performance of multifocal and progressive eyeglass lenses for presbyopia correction. These lenses provide a more natural and seamless transition between different vision zones.

Custom wavefront-guided treatments are being used in refractive surgeries to address higher-order aberrations, leading to better visual quality, especially in low-light conditions. Silicone hydrogel contact lenses offer improved comfort, breathability, and extended wear options for myopia and presbyopia correction. Phakic Intraocular Lenses, used in surgical myopia correction, have seen advancements in lens materials, design, and implantation techniques, enhancing safety and outcomes. Extended Depth of Focus (EDOF) intraocular lenses are designed to provide clear vision at multiple distances without the need for reading glasses. Technological improvements in these lenses have enhanced visual outcomes.

Telemedicine has become more prevalent in eye care. Digital refraction tools enable remote vision assessments and prescription updates for myopia and presbyopia patients. AI algorithms can assist in diagnosing myopia and presbyopia and predict disease progression, helping clinicians make more informed treatment decisions. Mobile apps and software have been developed to educate individuals about myopia and presbyopia and to offer vision training and monitoring programs. Gene therapy research holds promise for the treatment of myopia by targeting genetic factors associated with the condition. This factor will help in the development of the Global Myopia and Presbyopia Treatment Market.

Rising Aging Population

Presbyopia is an age-related vision condition that typically begins to affect individuals in their 40s. As people age, the natural loss of elasticity in the eye's crystalline lens makes it challenging to focus on close objects. This results in the need for reading glasses or other presbyopia treatments. Therefore, an aging population directly leads to a higher prevalence of presbyopia, which drives the demand for presbyopia treatment options. Myopia, or nearsightedness, often develops during childhood and adolescence but can continue to progress into adulthood. With age, the progression of myopia may result in worsening vision, making it necessary for individuals to seek myopia control and treatment options. As the aging population includes individuals who may have had myopia from a young age, the need for myopia treatment persists.

Some individuals may develop both myopia and presbyopia as they age. These dual vision conditions require comprehensive treatment, often involving prescription eyeglasses or contact lenses to address both nearsightedness and age-related farsightedness. Clear vision is essential for maintaining a high quality of life and remaining productive as people age. Correcting myopia and presbyopia ensures that individuals can continue to perform daily tasks, work, and enjoy recreational activities. Aging individuals are more likely to seek advanced treatment options for vision correction, benefiting from technological advancements in eyeglasses, contact lenses, intraocular lenses, and surgical procedures.

Aging populations typically have more regular healthcare check-ups, including eye examinations, which can lead to the diagnosis of myopia and presbyopia. This promotes the early detection and management of these conditions, further driving the demand for treatment. As the aging population often possesses greater financial stability and access to healthcare, they are more inclined to invest in effective vision correction solutions. Older individuals may also be more motivated to address vision issues early to prevent further complications and ensure that age-related eye diseases, like cataracts, are managed appropriately. Public health campaigns and educational efforts targeting the aging population raise awareness about the importance of regular eye check-ups and available treatments, further driving demand. This factor will pace up the demand of the Global Myopia and Presbyopia Treatment Market.

Increasing Pharmaceutical Innovations

Pharmaceutical innovations, such as low-dose atropine eye drops and other myopia control agents, have shown promise in slowing the progression of myopia, especially in children. These treatments are increasingly sought after by parents and eyecare professionals who wish to manage myopia effectively. Ongoing research and development efforts have focused on pharmaceutical eye drops designed to improve near vision in individuals with presbyopia. These innovations offer potential alternatives to traditional reading glasses or multifocal contact lenses. Pharmaceutical treatments can offer more convenient and patient-friendly solutions, especially for individuals who may be averse to wearing corrective lenses. The ease of using eye drops or pharmaceutical interventions can drive demand, particularly among those with presbyopia. Pharmaceutical treatments for myopia control are appealing to parents who want to intervene early to prevent their children's myopia from worsening. As the understanding of the long-term risks associated with high myopia grows, the demand for pharmaceutical interventions also increases.

Some patients prefer pharmaceutical interventions over surgical procedures for vision correction. Innovations in pharmaceuticals offer non-invasive or minimally invasive alternatives, attracting individuals who seek less invasive treatment options. Advances in pharmacogenomics and genetic testing can enable more personalized pharmaceutical treatments, tailoring interventions to an individual's genetic predisposition for myopia and presbyopia. Ongoing research explores combination therapies that incorporate pharmaceutical interventions with other treatment modalities, such as contact lenses or vision training programs. These integrated approaches offer a comprehensive solution for myopia and presbyopia.

Pharmaceutical companies continue to invest in research and development efforts focused on myopia and presbyopia treatments. This investment results in a broader range of treatment options, driving demand for these innovations. As pharmaceutical treatments for myopia control and presbyopia receive regulatory approvals, they become more widely accepted and adopted by eyecare professionals and patients. Educational campaigns and public awareness efforts by pharmaceutical companies and healthcare organizations inform consumers about the availability and benefits of pharmaceutical innovations, increasing demand. This factor will accelerate the demand of the Global Myopia and Presbyopia Treatment Market.

Key Market Challenges

Resistance to Surgery

Many individuals are afraid and apprehension about undergoing surgical procedures, especially when it involves their eyes. Concerns about pain, complications, and potential side effects can deter patients from considering surgery as a treatment option. Patients often prefer non-invasive or minimally invasive treatment options over surgery. Corrective eyewear, such as eyeglasses and contact lenses, are non-invasive and do not involve any surgical risk. Corrective lenses offer convenience and flexibility, allowing patients to easily remove or adjust them as needed. Surgery, on the other hand, may require a more significant commitment of time and effort. All surgical procedures carry inherent risks, including infection, inflammation, or complications that can affect vision. The potential risks and uncertainties associated with surgery can be a deterrent for some patients. Surgery for myopia and presbyopia can be expensive, and not all patients can afford it. Corrective eyewear or pharmaceutical treatments may be more cost-effective alternatives. Patients may be concerned about the long-term impact of surgical procedures, such as the potential need for follow-up surgeries or adjustments. They may prefer solutions that provide greater long-term stability. Some individuals, particularly older patients, or those with underlying health conditions, may not be suitable candidates for surgical procedures. This limits their treatment options and may lead to resistance to surgery.

Safety and Efficacy Concerns

Patients may be reluctant to try new treatments or technologies due to concerns about their safety and effectiveness. This reluctance can delay or limit the adoption of innovative solutions. Some treatment options, especially emerging technologies, may lack a well-established track record for long-term safety and efficacy. Patients may be hesitant to try these treatments without assurance of positive outcomes. Surgical procedures and certain treatments carry a risk of complications, including infection, inflammation, or post-operative issues. Patients are concerned about potential adverse events and the impact on their vision. For patients with myopia or presbyopia, the long-term effectiveness of treatments is a significant concern. They want assurance that the treatment will provide sustained benefits over time. Ensuring the safety and efficacy of new treatments and devices is a complex process that requires compliance with regulatory standards. Some treatments may face delays or challenges in gaining regulatory approval. Patient responses to treatments can vary, and there is no one-size-fits-all solution. This can lead to concerns about whether a treatment will work effectively for an individual. Emerging treatments may have limited clinical data available, making it difficult for patients to assess their safety and efficacy based on established evidence. Patients have high expectations when it comes to their vision, and they want treatments to meet or exceed those expectations. If treatments fall short, patient dissatisfaction and concerns about efficacy can arise.

Key Market Trends

Personalized Medicine

Personalized medicine considers the genetic factors that may contribute to myopia or presbyopia. Understanding an individual's genetic predisposition can help clinicians make more precise treatment decisions. Pharmacogenomic research focuses on how genetic variations can affect a person's response to medications. This approach can guide the choice of pharmaceutical treatments and their dosages based on a patient's genetic profile. Rather than a one-size-fits-all approach, personalized medicine allows for the creation of customized treatment plans that address the unique needs and characteristics of each patient. For myopia, personalized medicine can involve the selection of specific interventions, such as atropine eye drops or orthokeratology, based on a patient's age, rate of myopia progression, and genetic factors that may influence their response to treatment. In the case of presbyopia, personalized medicine considers factors such as the patient's age, visual demands, and the presence of any concurrent vision conditions when recommending treatments like progressive eyeglasses, multifocal contact lenses, or pharmaceutical options. Lifestyle factors, such as screen time, outdoor activities, and near-work habits, can impact myopia progression. Personalized medicine may involve recommending lifestyle changes or interventions that suit the patient's specific habits and needs. Personalized medicine also includes regular monitoring and adjustments to the treatment plan as needed. Clinicians can adapt treatments based on how an individual responds over time.

Segmental Insights

Presbyopia Treatment Type Insights

In 2023, the Global Myopia and Presbyopia Treatment Market largest share was held by Prescription segment in the forecast period and is predicted to continue expanding over the coming years. Presbyopia is an age-related vision problem that affects nearly everyone as they get older. It is a natural part of the aging process and typically begins to impact individuals in their 40s. As a result, there is a large and growing market for presbyopia treatment. Eyeglasses with prescription lenses are a primary and highly effective treatment for presbyopia. Multifocal or progressive addition lenses, commonly prescribed for presbyopia, provide clear vision for both near and distance tasks, and they are well-accepted by patients. Eyecare professionals can prescribe customized prescription lenses that precisely address the individual visual needs of patients. This level of customization ensures accurate and comfortable vision correction for presbyopia. Many individuals prefer prescription eyeglasses as a treatment for presbyopia due to their simplicity, comfort, and immediate effectiveness. Corrective lenses offer clear vision without the need for invasive procedures. Prescription eyewear, especially reading glasses and multifocal lenses, is widely accessible and commonly used by individuals experiencing presbyopia. People are familiar with these options and often turn to them for vision correction. Health insurance plans in many regions typically cover the cost of prescription eyeglasses for presbyopia. This makes it an affordable and practical choice for patients.

Regional Insights

The North America region dominates the Global Myopia And Presbyopia Treatment Market in 2023. North America, particularly the United States and Canada, boasts a well-developed and advanced healthcare infrastructure. This infrastructure includes a high density of eye care professionals, modern medical facilities, and access to the latest medical technologies and treatments. The region is a hub for innovation and technological advancements in the healthcare and ophthalmology sectors. Research and development of new treatments, surgical procedures, and diagnostic tools for myopia and presbyopia are prevalent in North America. North America typically has higher healthcare spending per capita compared to many other regions. This allows for greater investment in research, development, and adoption of new treatments and technologies. The presence of prominent pharmaceutical companies and biotech firms in North America facilitates the development of pharmaceutical treatments for myopia and presbyopia. This includes the creation of eye drops and medications aimed at controlling myopia progression.

Key Market Players

Ziemer Ophthalmic Systems AG

NIDEK CO., LTD.

Johnson & Johnson Vision Care, Inc.

Essilor

Carl Zeiss AG

Alcon

Bausch + Lomb Corporation

Haag-Streit UK

Topcon Corporation

Report Scope:

In this report, the Global Myopia and Presbyopia Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Myopia and Presbyopia Treatment Market, By Myopia Treatment Type:

    Corrective Surgical Drugs

Myopia And Presbyopia Treatment Market, By Presbyopia Treatment Type:

    Prescription Contact Lenses Intraocular Lenses Refractive Surgery

Myopia And Presbyopia Treatment Market, By Region:

    North America

United States

Canada

Mexico

    Europe

France

United Kingdom

Italy

Germany

Spain

    Asia-Pacific

China

India

Japan

Australia

South Korea

    South America

Brazil

Argentina

Colombia

    Middle East & Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Myopia And Presbyopia Treatment Market.

Available Customizations:

Global Myopia And Presbyopia Treatment market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Myopia And Presbyopia Treatment Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Myopia Treatment Type (Corrective, Surgical, Drugs)
    • 5.2.2. By Presbyopia Treatment Type (Prescription, Contact Lenses, Intraocular Lenses, Refractive Surgery)
    • 5.2.3. By Region
    • 5.2.4. By Company (2023)
  • 5.3. Market Map

6. North America Myopia And Presbyopia Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Myopia Treatment Type
    • 6.2.2. By Presbyopia Treatment Type
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Myopia And Presbyopia Treatment Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Myopia Treatment Type
        • 6.3.1.2.2. By Presbyopia Treatment Type
    • 6.3.2. Canada Myopia And Presbyopia Treatment Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Myopia Treatment Type
        • 6.3.2.2.2. By Presbyopia Treatment Type
    • 6.3.3. Mexico Myopia And Presbyopia Treatment Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Myopia Treatment Type
        • 6.3.3.2.2. By Presbyopia Treatment Type

7. Europe Myopia And Presbyopia Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Myopia Treatment Type
    • 7.2.2. By Presbyopia Treatment Type
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Myopia And Presbyopia Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Myopia Treatment Type
        • 7.3.1.2.2. By Presbyopia Treatment Type
    • 7.3.2. United Kingdom Myopia And Presbyopia Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Myopia Treatment Type
        • 7.3.2.2.2. By Presbyopia Treatment Type
    • 7.3.3. Italy Myopia And Presbyopia Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Myopia Treatment Type
        • 7.3.3.2.2. By Presbyopia Treatment Type
    • 7.3.4. France Myopia And Presbyopia Treatment Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Myopia Treatment Type
        • 7.3.4.2.2. By Presbyopia Treatment Type
    • 7.3.5. Spain Myopia And Presbyopia Treatment Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Myopia Treatment Type
        • 7.3.5.2.2. By Presbyopia Treatment Type

8. Asia-Pacific Myopia And Presbyopia Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Myopia Treatment Type
    • 8.2.2. By Presbyopia Treatment Type
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Myopia And Presbyopia Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Myopia Treatment Type
        • 8.3.1.2.2. By Presbyopia Treatment Type
    • 8.3.2. India Myopia And Presbyopia Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Myopia Treatment Type
        • 8.3.2.2.2. By Presbyopia Treatment Type
    • 8.3.3. Japan Myopia And Presbyopia Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Myopia Treatment Type
        • 8.3.3.2.2. By Presbyopia Treatment Type
    • 8.3.4. South Korea Myopia And Presbyopia Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Myopia Treatment Type
        • 8.3.4.2.2. By Presbyopia Treatment Type
    • 8.3.5. Australia Myopia And Presbyopia Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Myopia Treatment Type
        • 8.3.5.2.2. By Presbyopia Treatment Type

9. South America Myopia And Presbyopia Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Myopia Treatment Type
    • 9.2.2. By Presbyopia Treatment Type
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Myopia And Presbyopia Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Myopia Treatment Type
        • 9.3.1.2.2. By Presbyopia Treatment Type
    • 9.3.2. Argentina Myopia And Presbyopia Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Myopia Treatment Type
        • 9.3.2.2.2. By Presbyopia Treatment Type
    • 9.3.3. Colombia Myopia And Presbyopia Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Myopia Treatment Type
        • 9.3.3.2.2. By Presbyopia Treatment Type

10. Middle East and Africa Myopia And Presbyopia Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Myopia Treatment Type
    • 10.2.2. By Presbyopia Treatment Type
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Myopia And Presbyopia Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Myopia Treatment Type
        • 10.3.1.2.2. By Presbyopia Treatment Type
    • 10.3.2. Saudi Arabia Myopia And Presbyopia Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Myopia Treatment Type
        • 10.3.2.2.2. By Presbyopia Treatment Type
    • 10.3.3. UAE Myopia And Presbyopia Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Myopia Treatment Type
        • 10.3.3.2.2. By Presbyopia Treatment Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Myopia And Presbyopia Treatment Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Ziemer Ophthalmic Systems AG
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Key Personnel
    • 14.1.5. SWOT Analysis
  • 14.2. NIDEK CO., LTD.
  • 14.3. Johnson & Johnson Vision Care, Inc.
  • 14.4. Essilor
  • 14.5. Carl Zeiss AG
  • 14.6. Alcon
  • 14.7. Bausch + Lomb Corporation
  • 14.8. Haag-Streit UK
  • 14.9. Topcon Corporation

15. Strategic Recommendations

16.About Us & Disclaimer

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제